Antiviral agents in respiratory infections

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Viral respiratory illnesses are a significant public health concern in the United States.
• Limited therapeutic options were previously available for these common infections.

Purpose of the Study:

• To review current and emerging strategies for preventing and treating viral respiratory infections.
• To highlight the role of diagnostics in guiding targeted antiviral therapy.
• To discuss the potential and limitations of broad-spectrum antiviral agents.

Main Methods:

• Review of current literature on viral respiratory infections and their management.
• Analysis of therapeutic interventions for specific viruses like influenza and the common cold.
• Discussion of diagnostic approaches, including epidemiological, clinical, and laboratory methods.
• Evaluation of novel broad-spectrum antiviral drug development and delivery challenges.

Main Results:

• Specific and nonspecific agents are now available for prevention and treatment.
• Understanding pathogenesis has led to targeted therapies (e.g., common cold).
• Influenza treatment requires specific diagnostics for effective antiviral use.
• A broad-spectrum antiviral drug shows promise but requires a more practical delivery system.

Conclusions:

• Advances in virology and diagnostics are improving the management of viral respiratory illnesses.
• The development of effective broad-spectrum antiviral drugs is ongoing, but delivery remains a hurdle.
• Personalized and effective treatment strategies are becoming increasingly feasible for respiratory viral infections.